“According to S&S Insider, The Proteomics Market was valued at USD 30.61 billion in 2023 and is projected to grow to USD 96.35 billion by 2032, expanding at a compound annual growth rate (CAGR) of ...
Early clinical studies demonstrate that KIT inhibition has the potential to revolutionize the treatment of a broad range of mast-cell-mediated inflammatory diseases, and that a titratable, oral small ...